Matthieu Amalric1, Engi Ahmed2, Boris Jung1,2, Carey Suehs3, Nicolas Molinari3, Arnaud Bourdin2, Jeremy Charriot4. 1. Medical Intensive Care Unit, Montpellier University and Montpellier University Health Care Center, 34295, Montpellier, France. 2. Department of Respiratory Diseases, Montpellier University, CHU Montpellier, PhyMedExp, INSERM, CNRS, Montpellier, France. 3. Department of Medical Information, Montpellier University, Montpellier, France. 4. Department of Respiratory Diseases, Montpellier University, CHU Montpellier, PhyMedExp, INSERM, CNRS, Montpellier, France. j-charriot@chu-montpellier.fr.
Abstract
BACKGROUND: The course of chronic obstructive pulmonary disease (COPD) is punctuated by exacerbations, most often of infectious origin, responsible for many intensive care unit (ICU) and intermediate care unit (IMCU) admissions. Our objective was to study in-hospital mortality during severe COPD exacerbations in ICU and IMCU based on the performance of bronchoscopy. METHODS: A retrospective analysis was carried out on stays in ICUs for COPD exacerbation from the French Programme for the Medicalisation of Information Systems databases for the years 2014 and 2015. Propensity score matching of stays made it possible to constitute two comparable groups on the factors of excess mortality described in the literature (age, sex, SAPS 2, type of admission and bronchial tumour). RESULTS: We identified 14,491 stays for COPD exacerbation in ICUs, 2586 of which received a bronchoscopy. Mortality was significantly higher in the fibroscopy group (31.32% versus 19.8%). After propensity score matching, we found an excess of mortality in the intervention group (OR = 1.749 [1.516-2.017]) associated with a significantly longer length of stay. The main diagnoses associated with an increased risk of death were pulmonary embolism (OR = 3.251 [1.126-9.384]), bacterial pneumonia (OR = 1.906 [1.173-3.098]) and acute respiratory failure (OR = 1.840 [1.486-2.278]). CONCLUSIONS: Performing bronchoscopy during ICU hospitalisations for severe COPD exacerbations was associated with increased mortality. This increased mortality appears to be related to a bias in patient selection with a procedure reserved for patients with the adverse course.
BACKGROUND: The course of chronic obstructive pulmonary disease (COPD) is punctuated by exacerbations, most often of infectious origin, responsible for many intensive care unit (ICU) and intermediate care unit (IMCU) admissions. Our objective was to study in-hospital mortality during severe COPD exacerbations in ICU and IMCU based on the performance of bronchoscopy. METHODS: A retrospective analysis was carried out on stays in ICUs for COPD exacerbation from the French Programme for the Medicalisation of Information Systems databases for the years 2014 and 2015. Propensity score matching of stays made it possible to constitute two comparable groups on the factors of excess mortality described in the literature (age, sex, SAPS 2, type of admission and bronchial tumour). RESULTS: We identified 14,491 stays for COPD exacerbation in ICUs, 2586 of which received a bronchoscopy. Mortality was significantly higher in the fibroscopy group (31.32% versus 19.8%). After propensity score matching, we found an excess of mortality in the intervention group (OR = 1.749 [1.516-2.017]) associated with a significantly longer length of stay. The main diagnoses associated with an increased risk of death were pulmonary embolism (OR = 3.251 [1.126-9.384]), bacterial pneumonia (OR = 1.906 [1.173-3.098]) and acute respiratory failure (OR = 1.840 [1.486-2.278]). CONCLUSIONS: Performing bronchoscopy during ICU hospitalisations for severe COPD exacerbations was associated with increased mortality. This increased mortality appears to be related to a bias in patient selection with a procedure reserved for patients with the adverse course.
Authors: M Woodhead; F Blasi; S Ewig; G Huchon; M Ieven; M Leven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; T J M Verheij Journal: Eur Respir J Date: 2005-12 Impact factor: 16.671
Authors: A Torres; M el-Ebiary; L Padró; J Gonzalez; J P de la Bellacasa; J Ramirez; A Xaubet; M Ferrer; R Rodriguez-Roisin Journal: Am J Respir Crit Care Med Date: 1994-02 Impact factor: 21.405
Authors: J Chastre; J Y Fagon; M Bornet-Lecso; S Calvat; M C Dombret; R al Khani; F Basset; C Gibert Journal: Am J Respir Crit Care Med Date: 1995-07 Impact factor: 21.405
Authors: C H Marquette; M C Copin; F Wallet; R Neviere; F Saulnier; D Mathieu; A Durocher; P Ramon; A B Tonnel Journal: Am J Respir Crit Care Med Date: 1995-06 Impact factor: 21.405